Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

Leukocyte Removal Filter (Transfusion) - ANVISA Registration 10154450211

Access comprehensive regulatory information for Leukocyte Removal Filter (Transfusion) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450211 and manufactured by FRESENIUS HEMOCARE BRASIL LTDA.. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Jun 13, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including FRESENIUS HEMOCARE BRASIL LTDA., HAEMONETICS CORPORATION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
5 Recent Registrations
10154450211
Registration Details
ANVISA Registration Number: 10154450211
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

BioR flex - filtros para remoção de leucócitos (beira leito)
Risk Class III

Registration Details

10154450211

25351662138202181

49601107000184

Company Information

Brazil
PT: BRASIL

Dates and Status

Jun 13, 2022

13/06/2032

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "Leukocyte Removal Filter (Transfusion)"